证券代码：300138 证券简称：晨光生物 公告编号：2025—072 晨光生物科技集团股份有限公司 截至公告披露日，莎车晨光提前归还了昆仑银行上述借款，公司减少了对应 的 5,000 万元担保义务。 二、累计对外担保情况 上述担保情况变动后，公司及子公司累计决议对合并报表范围内主体融资担 保总额为 250,000 万元，占公司最近一期经审计净资产的 80.40%，其中：已签 订协议担保额度为 108,725 万元（本次担保情况变动前，已签订协议担保余额为 113,725 万元）。 关于子公司归还银行借款暨为子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 晨光生物科技集团股份有限公司（以下简称"公司"）对合并报表范围内子 公司银行借款担保情况因业务进展发生了变动，现公告如下： 一、对外担保基本情况及进展 结合自身经营流动资金需求，经公司 2023 年年度股东大会决议，晨光生物 科技集团莎车有限公司（简称"莎车晨光"）前期向昆仑银行股份有限公司库尔 勒分行（简称"昆仑银行"）申请办理了 5,000 万元流动资金借款，担保方式： 公司保证 ...

Core Insights - The article highlights the remarkable transformation of Chenguang Biotech Group from a hardware manufacturer to a leader in the plant extraction industry, driven by its founder, Lu Qingguo [1][2]. Group 1: Company Development - Chenguang Biotech was originally a hardware factory in Hebei, producing simple tools, but identified a significant market opportunity in the demand for chili red pigment, leading to its strategic pivot towards plant extraction [3][4]. - The company faced numerous challenges in developing extraction technology, as there were no existing successful models in China, prompting Lu Qingguo to innovate by adapting equipment from other industries [4][5]. - The production capacity of Chenguang's extraction lines has significantly increased, from processing 40 tons of dried chili per day in 2003 to 2000 tons in the latest version, showcasing the company's rapid growth and technological advancement [4]. Group 2: Innovation and R&D - Chenguang Biotech has established multiple research platforms and invested approximately 100 million yuan annually in R&D, resulting in over 440 patents and numerous awards [7][8]. - The company has successfully developed a revolutionary extraction technology for lycopene from tomato peels and seeds, which were previously considered waste, demonstrating its commitment to innovation [5][6]. - The introduction of high-level technical talent has been crucial for the company's growth, with over 660 professionals now contributing to its R&D efforts [8]. Group 3: Agricultural Integration - Chenguang Biotech has implemented a "company + cooperative + base + farmer" model to enhance agricultural productivity and income for local farmers, particularly in the western regions of China [9][10]. - The initiative has led to a significant increase in farmers' income, with earnings from planting marigolds rising from 600-700 yuan per mu to 2000-3000 yuan per mu [9][10]. - By directly participating in the agricultural production process, the company ensures a reliable supply of raw materials while fostering a win-win situation for both the enterprise and the farmers [10].

Core Viewpoint - The success of Chenguang Biotech Group is attributed to its founder, Lu Qingguo, who emphasizes innovation and talent as key drivers for the company's growth in the plant extraction industry. Group 1: Company Development - Chenguang Biotech started as a hardware factory in 1998 and transitioned to the plant extraction industry after identifying a significant market demand for chili red pigment [2] - The company faced challenges in technology acquisition but overcame them by innovating and adapting equipment from other industries to create its own production line for chili extraction, which began operations in 2003 [3] - The production capacity of Chenguang's extraction lines has significantly increased from 40 tons to 2000 tons, showcasing continuous improvement and innovation [3] Group 2: Technological Innovation - Chenguang Biotech developed a revolutionary method for extracting lycopene from tomato peels and seeds, which were previously considered waste [4] - The company invested 1 billion yuan annually in R&D, resulting in over 440 patents and 55 provincial and national technology awards [6] Group 3: Talent Acquisition and Retention - The company has established 26 research platforms and employs over 200 high-level technical talents, recognizing the importance of skilled personnel in driving innovation [6] - Chenguang Biotech has implemented strategies to improve working conditions and compensation to attract and retain talent, including building innovation centers and providing housing for employees [7] Group 4: Agricultural Collaboration - Chenguang Biotech has developed a model of "company + cooperative + base + farmer" to enhance agricultural productivity and income for local farmers, particularly in the western regions of China [8] - The company has established 10 deep processing factories in the west, promoting the cultivation of various crops and ensuring a stable supply of raw materials [9] - This collaborative approach not only benefits farmers but also allows the company to maintain control over the quality of its raw materials, leading to a win-win situation [9]

Core Insights - The article highlights the remarkable transformation of Chenguang Biotech Group from a hardware manufacturer to a leader in the plant extraction industry, driven by the vision and efforts of its founder, Lu Qingguo [2][3] Group 1: Company Development - Chenguang Biotech started as a hardware factory in 1998 and shifted focus to plant extraction after identifying a market opportunity in the demand for capsanthin [3] - The company faced significant challenges in developing extraction technology, as there were no existing research results in China and foreign factories were inaccessible [3][4] - Lu Qingguo led the team to innovate and adapt equipment from other industries, resulting in the establishment of a chili extraction production line in 2003, capable of processing 40 tons of dried chili per day [4] Group 2: Technological Innovation - Chenguang Biotech expanded its product range from capsanthin to include natural colors, spices, essential oils, and natural sweeteners [5] - The company achieved a breakthrough in lycopene extraction from tomato peels and seeds, which were previously considered waste, through an 8-year research effort [5] - The company has invested approximately 100 million yuan annually in R&D, resulting in over 440 patents and 55 provincial and national technology awards [6] Group 3: Talent Acquisition and Retention - Chenguang Biotech has established 26 research platforms and employs over 200 high-level technical talents, recognizing the importance of technology and talent in its growth [6][7] - The company faced challenges in retaining talent due to its remote location, prompting Lu Qingguo to improve working conditions and compensation to attract and retain skilled professionals [6][7] Group 4: Agricultural Development - The company has implemented a "company + cooperative + base + farmer" model to enhance agricultural productivity in the western regions, leading to increased income for local farmers [8][9] - By establishing raw material bases and processing plants, Chenguang Biotech has created a win-win situation for both the company and farmers, ensuring a stable supply of quality raw materials [9]

内容概要：随着国民健康意识的不断提高，消费者对健康食品和功能性原料的需求日益增加，菊粉具有 膳食纤维和益生元的双重营养功能，对控制血脂、降低血糖、改善肠道健康等有显著效果，契合了消费 者对健康的追求，因此，近年来在健康食品、保健品等领域的需求持续攀升，据统计，2024年我国菊粉 需求量达1.82万吨，市场规模达4.5亿元，而同年产量仅1.65万吨，因此，每年仍需大量进口。 上市企业：晨光生物（300138） 相关企业：河北维乐夫农业科技有限公司、武汉英纽林生物科技有限公司、美泰科技（青岛）股份有限 公司、青海瑞湖生物资源开发有限公司、重庆骄王天然产物股份有限公司、青海威德生物技术有限公 司、山东益得来生物科技有限公司、内蒙古维你好生物科技有限公司、辽宁启康生物科技有限公司 关键词：菊粉发展历程、菊粉产业链、菊粉需求量、菊粉市场规模、菊粉竞争格局、菊粉发展趋势 一、概述 菊粉（Inulin）是一种天然存在的水溶性膳食纤维，属于果聚糖家族，其化学结构由多个D-呋喃果糖单 元通过β-2,1糖苷键连接而成，末端通常带有一个葡萄糖单元。它广泛存在于菊科植物（如菊苣、菊 芋）、天门冬科（如芦笋）等天然植物中，是植物储存能 ...

证券之星消息，8月5日农产品加工板块较上一交易日上涨0.98%，*ST中基领涨。当日上证指数报收于 3617.6，上涨0.96%。深证成指报收于11106.96，上涨0.59%。农产品加工板块个股涨跌见下表： 从资金流向上来看，当日农产品加工板块主力资金净流出960.38万元，游资资金净流出3683.66万元，散 户资金净流入4644.04万元。农产品加工板块个股资金流向见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 000972 | *ST中基 | 3.52 | 5.07% | 34.93万 | | 1.22亿 | | 300138 | 晨光生物 | 13.49 | 2.43% | 12.00万 | 1.60亿 | | | 600737 | 中粮糖业 | 10.01 | 2.14% | 23.43万 | | 2.34亿 | | 300175 | ST朗源 | 5.06 | 2.02% | 5.21万 | 2619.87万 | | | 600191 | 三四级 | 8. ...

证券之星消息，8月1日农产品加工板块较上一交易日下跌0.71%，安德利领跌。当日上证指数报收于 3559.95，下跌0.37%。深证成指报收于10991.32，下跌0.17%。农产品加工板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300138 | 晨光生物 | 13.43 | 2.21% | 15.81万 | 2.13亿 | | 600962 | 国投中鲁 | 18.98 | 1.61% | 6.63万 | 1.25亿 | | 603182 | 喜华股份 | 14.31 | 1.35% | 1.92万 | 2726.61万 | | 603231 | 索宝蛋白 | 17.17 | 1.12% | 1.83万 | 3147.97万 | | 002481 | 双塔食品 | 5.35 | 0.75% | 7.36万 | 3925.01万 | | 300268 | *ST佳沃 | 10.26 | 0.69% | 1.55万 | 1592.77万 | | 001338 | 永顺泰 ...

证券日报网讯晨光生物（300138）7月31日在互动平台回答投资者提问时表示，棉籽类业务因偏大宗商 品属性呈现出收入体量大、波动性强、毛利率低的特点。公司将持续推进棉籽类业务独立发展，实现整 体效益最大化。 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 605198 | 安德利 | 51.81 | 8.98% | 6.15万 | | 3.07亿 | | 600191 | 一周边 | 7.72 | 0.65% | 6.09万 | 4666.43万 | | | 300138 | 晨光生物 | 13.14 | 0.00% | 7.59万 | 9999.93万 | | | 002852 | 道道全 | 12.13 | -0.16% | 21.77万 | | 2.63亿 | | 002286 | 保龄宝 | 10.53 | -0.57% | 8.74万 | 9238.66万 | | | 300175 | ST朗源 | 5.06 | -0.98% | 4.87万 | 2486.14万 | | | 600737 | 中粮糖业 | 9.79 | -1.51% | 18.32万 | | 1.80亿 | | 003030 | 祖名股份 | 19.07 | -1.55% | 1.88万 | 3620.6 ...

Group 1 - The company, Morning Light Bio, announced that it has officially obtained a patent certificate issued by the National Intellectual Property Administration [2] - The subsidiary, Hebei Morning Light Testing Technology Service Co., Ltd., has also received a software copyright registration certificate from the National Copyright Administration [2]